BioMalPar XXI: biology and pathology of the malaria parasite (BioMalPar 2025)
BioMalPar reaffirms its commitment to understanding the Plasmodium parasite and its interactions with hosts and vectors. Despite the challenges, there are promising developments: new drug combinations are showing efficacy, and we now have two approved vaccines that offer hope for the future. For the 21st time the EMBL meeting, Biology and Pathology of the Malaria Parasite (BioMalPar 2025) focusses on strengthening the global research community by fostering new partnerships and collaborations.
Date: May 20 – 22, 2025
Place: virtual and Heidelberg, Germany
BioMalPar acknowledges that defeating malaria requires a united effort across continents and disciplines – and reflects this with by a diverse line-up of speakers. The upcoming conference provides an invaluable platform for scientists worldwide to convene, share critical insights, and explore cutting-edge technologies.
Together, we can drive forward the innovations and strategies needed to reduce the terrible toll malaria takes. Join us in this crucial endeavour to understand the biology of the malaria parasite and to advance global health.
Session topics:
- Epidemiology – the epidemiology of malaria in endemic countries
- Vaccines and immunity – how vaccines can alter this landscape
- Vector and transmission – what role transmission through the mosquito vector plays
- Molecular and cellular biology – the molecular and cellular biology of the parasite
- Drug targets and resistance – and how we can use these findings to find new drug targets and combat resistance
Important dates:
- Abstract Deadline – February 25, 2025
- Registration (On-site) Deadline – April 8, 2025
- Registration (Virtual) Deadline – April 29, 2025
Read more here.
